Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Trop Med Int Health. 2018 Mar;23(3):270-278. doi: 10.1111/tmi.13026. Epub 2018 Jan 9.
OBJECTIVES: To assess adherence outcomes to antiretroviral therapy (ART) of recipients ≥50 years in Soweto, South Africa. METHODS: This was a secondary data analysis for a cross-sectional study at two HIV clinics in Soweto. Data on ART adherence and covariates were gathered through structured interviews with HIV 878 persons living with HIV (PLHIV) receiving ART. Logistic regression analysis was used to assess associations. RESULTS: PLHIV ≥50 years (n = 103) were more likely to miss clinic visits during the last six months than PLHIV aged 25-49 (OR 2.15; 95%CI 1.10-4.18). PLHIV ≥50 years with no or primary-level education were less likely to have missed a clinic visit during the last six months than PLHIV with secondary- or tertiary-level education in the same age category (OR 0.3; 95%CI 0.1-1.1), as were PLHIV who did not disclose their status (OR 0.2; 95%CI 0-1.1). There was no evidence of increased risk for non-adherence to ART pills and drug refill visits among older PLHIV. CONCLUSION: Missing a clinic visit was more common among older PLHIV who were more financially vulnerable. Further studies are needed to verify these findings and identify new risk factors associated with ART adherence.
目的:评估南非索韦托≥50 岁接受抗逆转录病毒治疗(ART)的患者的治疗依从性结果。
方法:这是在索韦托的两家 HIV 诊所进行的一项横断面研究的二次数据分析。通过对正在接受 ART 的 878 名 HIV 感染者(PLHIV)进行结构化访谈,收集了关于 ART 依从性和协变量的数据。使用逻辑回归分析评估关联。
结果:≥50 岁的 PLHIV(n=103)在过去六个月中错过就诊的可能性大于 25-49 岁的 PLHIV(OR 2.15;95%CI 1.10-4.18)。在≥50 岁的 PLHIV 中,没有或仅接受过小学教育的人在过去六个月中错过就诊的可能性小于同年龄组中接受过中学或高等教育的人(OR 0.3;95%CI 0.1-1.1),未透露其身份的 PLHIV(OR 0.2;95%CI 0-1.1)也是如此。没有证据表明年龄较大的 PLHIV 对 ART 药物和药物补充就诊的依从性风险增加。
结论:经济上较为脆弱的老年 PLHIV 更常错过就诊。需要进一步的研究来验证这些发现,并确定与 ART 依从性相关的新风险因素。
J Int Assoc Provid AIDS Care. 2016-11
PLOS Glob Public Health. 2025-4-24
S Afr Fam Pract (2004). 2022-6-29
AIDS Res Ther. 2022-1-7